Models of Charcot-Marie-Tooth Disease

Myelin Biology and Disorders

Volumn 2, Issue , 2004, Pages 1143-1168

  Wrabetz, Lawrence ^a   Feltri, Maria Laura ^a   Suter, Ueli ^b  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b ETH ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84903010668     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012439510-7/50101-7     Document Type: Chapter

References (209)

1. Abel A., Bone L.J., Messing A., Scherer S.S., Fischbeck K.H. Studies in transgenic mice indicate a loss of connexin32 function in X-linked Charcot-Marie-Tooth disease. J Neuropathol Exp Neurol 1999, 58:702-710.
2. Adlkofer K., Frei R., Neuberg D.H., Zielasek J., Toyka K.V., Suter U. Heterozygous peripheral myelin protein 22-deficient mice are affected by a progressive demyelinating tomaculous neuropathy. J Neurosci 1997, 17:4662-4671.
3. Adlkofer K., Martini R., Aguzzi A., Zielasek J., Toyka K.V., Suter U. Hypermyelination and demyelinating peripheral neuropathy in Pmp22-deficient mice. Nat Genet 1995, 11:274-280.
4. Adlkofer K., Naef R., Suter U. Analysis of compound heterozygous mice reveals that the Trembler mutation can behave as a gain-of-function allele. J Neurosci Res 1997, 49:671-680.
5. Aguayo A.J., Attiwell M., Trecarten J., Perkins S., Bray G.M. Abnormal myelination in transplanted Trembler mouse Schwann cells. Nature 1977, 265:73-75.
6. Altevogt B.M., Kleopa K.A., Postma F.R., Scherer S.S., Paul D.L. Connexin29 is uniquely distributed within myelinating glial cells of the central and peripheral nervous systems. J Neurosci 2002, 22:6458-6470.
7. Anzini P., Neuberg D.H., Schachner M., Nelles E., Willecke K., Zielasek J., Toyka K.V., Suter U., Martini R. Structural abnormalities and deficient maintenance of peripheral nerve myelin in mice lacking the gap junction protein connexin 32. J Neurosci 1997, 17:4545-4551.
8. Arroyo E.J., Xu Y.T., Zhou L., Messing A., Peles E., Chiu S.Y., Scherer S.S. Myelinating Schwann cells determine the internodal localization of Kv1.1, Kv1.2, Kvbeta2, and Caspr. J Neurocytol 1999, 28:333-347.
9. Atanasoski S., Scherer S.S., Nave K.A., Suter U. Proliferation of Schwann cells and regulation of cyclin D1 expression in an animal model of Charcot-Marie-Tooth disease type 1A. J Neurosci Res 2002, 67:443-449.
10. Atanasoski S., Shumas S., Dickson C., Scherer S.S., Suter U. Differential cyclin D1 requirements of proliferating Schwann cells during development and after injury. Mol Cell Neurosci 2001, 18:581-592.
11. Ayers M.M., Anderson R.M. Onion bulb neuropathy in the Trembler mouse: A model of hypertrophic interstitial neuropathy (Dejerine-Sottas). in man. Acta Neuropathol 1973, 25:54-70.
12. Ayers M.M., Anderson R.M. Development of onion bulb neuropathy in the Trembler mouse. Comparison with normal nerve maturation. Acta Neuropathol 1975, 32:43-59.
13. Ayers M.M., Anderson R.M. Development of onion bulb neuropathy in the Trembler mouse. Morphometric study. Acta Neuropathol 1976, 36:137-152.
14. Balice-Gordon R.J., Bone L.J., Scherer S.S. Functional gap junctions in the schwann cell myelin sheath. J Cell Biol 1998, 142:1095-1104.
15. Bartoszewics Z.P., Lauter C.J., Quarles R.H. The myelin-associated glycoprotein of the peripheral nervous system in trembler mutants contains increased α2-3 sialic acid and galactose. J Neurosci Res 1996, 43:587-593.
16. Bascles L., Bonnet J., Garbay B. Expression of the PMP-22 gene in Trembler mutant mice: Comparison with the other myelin protein genes. Dev Neurosci 1992, 14:336-341.
17. Berciano J., Garcia A., Calleja J., Combarros O. Clinico-electrophysiological correlation of extensor digitorum brevis muscle atrophy in children with charcot-marie-tooth disease 1A duplication. Neuromuscul Disord 2000, 10:419-424.
18. Berger P., Young P., Suter U. Molecular cell biology of Charcot-Marie-Tooth disease. Neurogenetics 2002, 4:1-15.
19. Bergoffen J., Scherer S.S., Wang S., Scott M.O., Bone L.J., Paul D.L., Chen K., Lensch M.W., Chance P.F., Fischbeck K.H. Connexin mutations in X-linked Charcot-Marie-Tooth disease. Science 1993, 262:2039-2042.
20. Bird T.D. Historical perspective of defining Charcot-Marie-Tooth type 1B. Ann N Y Acad Sci 1999, 883:6-13.
21. Boerkoel C.F., Takashima H., Stankiewicz P., Garcia C.A., Leber S.M., Rhee-Morris L., Lupski J.R. Periaxin mutations cause recessive Dejerine-Sottas neuropathy. Am J Hum Genet 2001, 68:325-333.
22. Boiron-Sargueil F., Heape A., Garbay B., Cassagne C. Cerebroside formation in the peripheral nervous system of normal and Trembler mice. Neurosci Lett 1995, 186:21-24.
23. Braverman I.M. Neurological actions caused by the mutant gene "Trembler" in the house mouse (Mus musculus L.): An investigation. J Neuropathol Exp Neurol 1953, 12:64-72.
24. Britsch S., Goerich D.E., Riethmacher D., Peirano R.I., Rossner M., Nave K.A., Birchmeier C., Wegner M. The transcription factor Sox10 is a key regulator of peripheral glial development. Genes Dev 2001, 15:66-78.
25. Brownlees J., Ackerley S., Grierson A.J., Jacobsen N.J., Shea K., Anderton B.H., Leigh P.N., Shaw C.E., Miller C.C. Charcot-Marie-Tooth disease neurofilament mutations disrupt neurofilament assembly and axonal transport. Hum Mol Genet 2002, 11:2837-2844.
26. Cardoso F.E., Jankovic J. Hereditary motor-sensory neuropathy and movement disorders. Muscle Nerve 1993, 16:904-910.
27. Carenini S., Maurer M., Werner A., Blazyca H., Toyka K.V., Schmid C.D., Raivich G., Martini R. The role of macrophages in demyelinating peripheral nervous system of mice heterozygously deficient in P0. J Cell Biol 2001, 152:301-308.
28. Chance P.F., Dyck P.J. Hereditary neuropathy with liability to pressure palsies: A patient's point mutation in a mouse model. Neurology 1998, 51:664-665.
29. Chaouch M., Allal Y., De Sandre-Giovannoli A., Vallat J.M., Amer-el-Khedoud A., Kassouri N., Chaouch A., Sindou P., Hammadouche T., Tazir M., Levy N., Grid D. The phenotypic manifestations of autosomal recessive axonalCharcot-Marie-Tooth due to a mutation in Lamin A/C gene. Neuromuscul Disord 2003, 13:60-67.
30. Costaglioli P., Come C., Knoll-Gellida A., Salles J., Cassagne C., Garbay B. The homeotic protein dlk is expressed during peripheral nerve development. FEBS Lett 2001, 509:413-416.
31. D'Urso D., Brophy P.J., Staugaitis S.M., Gillespie C.S., Frey A.B., Stempak J.G., Colman D.R. Protein zero of peripheral nerve myelin: Biosynthesis, membrane insertion, and evidence for homotypic interaction. Neuron 1990, 4:449-460.
32. D'Urso D., Prior R., Greiner-Petter R., Gabreels-Festen A.A., Muller H.W. Overloaded endoplasmic reticulum-Golgi compartments, a possible pathomechanism of peripheral neuropathies caused by mutations of the peripheral myelin protein PMP22. J Neurosci 1998, 18:731-740.
33. D'Urso D., Schmalenbach C., Zoidl G., Prior R., Muller H.W. Studies on the effects of altered PMP22 expression during myelination in vitro. J Neurosci Res 1997, 48:31-42.
34. Darbas A., Jaegle M., Walbeehm E., Grosveld F.E., Meijer D. Schwann cell autonomy of the claw paw gene. Glia 2002, 38:S68.
35. De Jonghe P., Mersivanova I., Nelis E., Del Favero J., Martin J.J., Van Broeckhoven C., Evgrafov O., Timmerman V. Further evidence that neurofilament light chain gene mutations can cause Charcot-Marie-Tooth disease type 2E. Ann Neurol 2001, 49:245-249.
36. De Leon M., Nahin R.L., Mendoza M.E., Ruda M.A. SR13/PMP-22 expression in rat nervous system, in PC12 cells, and C6 glial cell lines. J Neurosci Res 1994, 38:167-181.
37. De Sandre-Giovannoli A., Chaouch M., Kozlov S., Vallat J.M., Tazir M., Kassouri N., Szepetowski P., Hammadouche T., Vandenberghe A., Stewart C.L., Grid D., Levy N. Homozygous defects in LMNA, encoding lamin A/C nuclear-envelope proteins, cause autosomal recessive axonal neuropathy in human (Charcot-Marie-Tooth disorder type 2)., and mouse. Am J Hum Genet 2002, 70:726-736.
38. de Waegh S., Brady S.T. Altered slow axonal transport and regeneration in a myelin-deficient mutant mouse: The trembler as an in vivo model for Schwann cell-axon interactions. J Neurosci 1990, 10:1855-1865.
39. de Waegh S.M., Brady S.T. Local control of axonal properties by Schwann cells: Neurofilaments and axonal transport in homologous and heterologous nerve grafts. J Neurosci Res 1991, 30:201-212.
40. de Waegh S.M., Lee V.M., Brady S.T. Local modulation of neurofilament phosphorylation, axonal caliber, and slow axonal transport by myelinating Schwann cells. Cell 1992, 68:451-463.
41. Dickson K.M., Bergeron J.J., Shames I., Colby J., Nguyen D.T., Chevet E., Thomas D.Y., Snipes G.J. Association of calnexin with mutant peripheral myelin protein-22 ex vivo: A basis for "gain-of-function" ER diseases. Proc Natl Acad Sci U S A 2002, 99:9852-9857.
42. Dyck P.J., Karnes J.L., Lambert E.H. Longitudinal study of neuropathic deficits and nerve conduction abnormalities in hereditary motor and sensory neuropathy type 1. Neurology 1989, 39:1302-1308.
43. Falconer D.S. Two new mutants, "Trembler" and "Reeler" with neurological actions in the house mouse. Genetics 1951, 50:192-201.
44. Filbin M., Walsh F., Trapp B., Pizzey J., Tennekoon G. Role of myelin Po protein as a homophilic adhesion molecule. Nature 1990, 344:871-872.
45. Fischbeck K.H., Abel A., Lin G.S., Scherer S.S. X-linked Charcot-Marie-Tooth disease and connexin32. Ann N Y Acad Sci 1999, 883:36-41.
46. Frei R., Motzing S., Kinkelin I., Schachner M., Koltzenburg M., Martini R. Loss of distal axons and sensory Merkel cells and features indicative of muscle denervation in hindlimbs of P0-deficient mice. J Neurosci 1999, 19:6058-6067.
47. Gabreels-Festen A.A., Joosten E.M., Gabreels F.J., Jennekens F.G., Janssen-van Kempen T.W. Early morphological features in dominantly inherited demyelinating motor and sensory neuropathy (HMSN type I). J Neurol Sci 1992, 107:145-154.
48. Garbay B., Boiron-Sargueil F., Cassagne C. Expression of the exon 1A-containing PMP22 transcript is altered in the trembler mouse. Neurosci Lett 1995, 198:157-160.
49. Garbay B., Boiron-Sargueil F., Shy M., Chbihi T., Jiang H., Kamholz J., Cassagne C. Regulation of oleoyl-CoA synthesis in the peripheral nervous system: Demonstration of a link with myelin synthesis. J Neurochem 1998, 71:1719-1726.
50. Garbay B., Bonnet J. P0 protein in normal, trembler heterozygous/homozygous mice during active PNS myelination. Neuroreport 1992, 3:594-596.
51. Garbay B., Cassagne C. Expression of the ceramide galactosyltransferase gene during myelination of the mouse nervous system. Comparison with the genes encoding myelin basic proteins, choline kinase and CTP:phosphocholine cytidyltransferase. Dev Brain Res 1994, 83:119-124.
52. Garbern J.Y., Cambi F., Tang X.M., Sima A.A., Vallat J.M., Bosch E.P., Lewis R., Shy M., Sohi J., Kraft G., Chen K.L., Joshi I., Leonard D.G., Johnson W., Raskind W., Dlouhy S.R., Pratt V., Hodes M.E., Bird T., Kamholz J. Proteolipid protein is necessary in peripheral as well as central myelin. Neuron 1997, 19:205-218.
53. Giese K.P., Martini R., Lemke G., Soriano P., Schachner M. Mouse P0 gene disruption leads to hypomyelination, abnormal expression of recognition molecules, and degeneration of myelin and axons. Cell 1992, 71:565-576.
54. Gillespie C.S., Sherman D.L., Blair G.E., Brophy P.J. Periaxin, a novel protein of myelinating Schwann cells with a possible role in axonal ensheathment. Neuron 1994, 12:497-508.
55. Gillespie C.S., Sherman D.L., Fleetwood-Walker S.M., Cottrell D.F., Tait S., Garry E.M., Wallace V.C., Ure J., Griffiths I.R., Smith A., Brophy P.J. Peripheral demyelination and neuropathic pain behavior in periaxin-deficient mice. Neuron 2000, 26:523-531.
56. Gow A., Southwood C.M., Lazzarini R.A. Disrupted proteolipid protein trafficking results in oligodendrocyte apoptosis in an animal model of Pelizaeus-Merzbacher disease. J Cell Biol 1998, 140:925-934.
57. Greenfield S., Brostoff S., Eylar E.H., Morell P. Protein composition of myelin of the peripheral nervous system. J. Neurochem 1973, 20:1207-1216.
58. Griffiths I., Klugmann M., Anderson T., Yool D., Thomson C., Schwab M.H., Schneider A., Zimmermann F., McCulloch M., Nadon N., Nave K.A. Axonal swellings and degeneration in mice lacking the major proteolipid of myelin. Science 1998, 280:1610-1613.
59. Guilbot A., Williams A., Ravise N., Verny C., Brice A., Sherman D.L., Brophy P.J., LeGuern E., Delague V., Bareil C., Megarbane A., Claustres M. A mutation in periaxin is responsible for CMT4F, an autosomal recessive form of Charcot-Marie-Tooth disease. Hum Mol Genet 2001, 10:415-421.
60. Hagedorn L., Suter U., Sommer L. P0 and PMP22 mark a multipotent neural crest-derived cell type that displays community effects in response to TGF-beta family factors. Development 1999, 126:3781-3794.
61. Hahn A.F., Parkes A.W., Bolton C.F., Stewart S.A. Neuromyotonia in hereditary motor neuropathy. J Neurol Neurosurg Psychiatry 1991, 54:230-235.
62. Heape A.M., Bessoule J.J., Boiron-Sargueil F., Cassagne C. Pathways of incorporation of fatty acid into glycerolipids of the murine peripheral nervous system in vivo: Alterations in the dysmyelinating mutant trembler mouse. Neurochem Int 1996, 29:607-622.
63. Heape A.M., Bessoule J.-J., Boiron-Sargueil F., Garbay B., Cassagne C. Sphingolipid metabolic disorders in Trembler mouse peripheral nerves in vivo result from an abnormal substrate supply. J Neurochem 1995, 65:1665-1673.
64. Heath J.W., Inuzuka T., Quarles R.H., Trapp B.D. Distribution of P0 protein and the myelin-associated glycoprotein in peripheral nerves from Trembler mice. J Neurocytol 1991, 20:439-449.
65. Henry E.W., Cowen J.S., Sidman R.L. Comparison of trembler and trembler-J phenotypes: Varying severity of peripheral hypomyelination. J Neuropathol Exp Neurol 1983, 42:688-706.
66. Henry E.W., Eicher E.M., Sidman R.L. The mouse mutation claw paw: Forelimb deformity and delayed myelination throughout the peripheral nervous system. J Hered 1991, 82:287-294.
67. Henry E.W., Sidman R.L. The murine mutation trembler-J: Proof of semi-dominant expression by the use of the linked vestigial tail marker. J Neurogen 1983, 1:39-52.
68. Henry E.W., Sidman R.L. Long lives for homozygous trembler mutant mice despite virtual absence of peripheral myelin. Science 1988, 241:344-346.
69. Huxley C., Passage E., Manson A., Putzu G., Figarella-Branger D., Pellissier J.F., Fontes M. Construction of a mouse model of Charcot-Marie-Tooth disease type 1A by pronuclear injection of human YAC DNA. Hum Mol Genet 1996, 5:563-569.
70. Huxley C., Passage E., Robertson A.M., Youl B., Huston S., Manson A., Saberan-Djoniedi D., Figarella-Branger D., Pellissier J.F., Thomas P.K., Fontes M. Correlation between varying levels of PMP22 expression and the degree of demyelination and reduction in nerve conduction velocity in transgenic mice. Hum Mol Geent 1998, 7:449-458.
71. Ingham P.W., McMahon A.P. Hedgehog signaling in animal development: Paradigms and principles. Genes Dev 2001, 15:3059-3087.
72. Inoue K., Dewar K., Katsanis N., Reiter L.T., Lander E.S., Devon K.L., Wyman D.W., Lupski J.R., Birren B. The 1.4-Mb CMT1A duplication/HNPP deletion genomic region reveals unique genome architectural features and provides insights into the recent evolution of new genes. Genome Res 2001, 11:1018-1033.
73. Inoue K., Shilo K., Boerkoel C.F., Crowe C., Sawady J., Lupski J.R., Agamanolis D.P. Congenital hypomyelinating neuropathy, central dysmyelination, and Waardenburg-Hirschsprung disease: Phenotypes linked by SOX10 mutation. Ann Neurol 2002, 52:836-842.
74. Inoue K., Tanabe Y., Lupski J.R. Myelin deficiencies in both the central and the peripheral nervous systems associated with a SOX 10 mutation. Ann Neurol 1999, 46:313-318.
75. Inuzuka T., Quarles R.H., Heath J., Trapp B.D. Myelin-associated glycoprotein and other proteins in Trembler mice. J Neurochem 1985, 44:793-797.
76. Ionasescu V.V., Searby C.C., Ionasescu R., Chatkupt S., Patel N., Koenigsberger R. Dejerine-Sottas neuropathy in mother and son with same point mutation of PMP22 gene. Muscle Nerve 1997, 20:97-99.
77. Isaacs A.M., Davies K.E., Hunter A.J., Nolan P.M., Vizor L., Peters J., Gale D.G., Kelsell D.P., Latham I.D., Chase J.M., Fisher E.M., Bouzyk M.M., Potter A., Masih M., Walsh F.S., Sims M.A., Doncaster K.E., Parsons C.A., Martin J., Brown S.D., Rastan S., Spurr N.K., Gray I.C. Identification of two new Pmp22 mouse mutants using large-scale mutagenesis and a novel rapid mapping strategy. Hum Mol Genet 2000, 9:1865-1871.
78. Jordanova A., De Jonghe P., Boerkoel C.F., Takashima H., De Vriendt E., Ceuterick C., Martin J.J., Butler I.J., Mancias P., Papasozomenos S.C., Terespolsky D., Potocki L., Brown C.W., Shy M., Rita D.A., Tournev I., Kremensky I., Lupski J.R., Timmerman V. Mutations in the neurofilament light chain gene (NEFL). cause early onset severe Charcot-Marie-Tooth disease. Brain 2003, 126:590-597.
79. Julien J.P., Couillard-Despres S., Meier J. Transgenic mice in the study of ALS: The role of neurofilaments. Brain Pathol 1998, 8:759-769.
80. Kirkpatrick L.L., Brady S.T. Modulation of the axonal microtubule cytoskeleton by myelinating Schwann cells. J Neurosci 1994, 14:7440-7450.
81. Kirschner D.A., Sidman R.L. X-ray diffraction study of myelin structure in immature and mutant mice. Biochim Biophys Acta 1976, 448:73-87.
82. Kirschner D.A., Szumowski K., Gabreel-Festen A.A.W.M., Gabreel-Festen J.E., Gabreel-Festen H., Gabreel-Festen P.A., Gabreel-Festen B. Inherited demyelinating peripheral neuropathies: Relating myelin packing abnormalities to Po molecular defects. J. Neurosci. Res. 1996, 46:502-508.
83. Kleopa K.A., Scherer S.S. Inherited neuropathies. Neurol Clin 2002, 20:679-709.
84. Kleopa K.A., Yum S.W., Scherer S.S. Cellular mechanisms of connexin32 mutations associated with CNS manifestations. J Neurosci Res 2002, 68:522-534.
85. Klugmann M., Schwab M.H., Puhlhofer A., Schneider A., Zimmermann F., Griffiths I.R., Nave K.A. Assembly of CNS myelin in the absence of proteolipid protein. Neuron 1997, 18:59-70.
86. Kobsar I., Maurer M., Ott T., Martini R. Macrophage-related demyclination in peripheral nerves of mice deficient in the gap junction protein connexin 32. Neurosci Lett 2002, 320:17-20.
87. Krajewski K.M., Lewis R.A., Fuerst D.R., Turansky C., Hinderer S.R., Garbern J., Kamholz J., Shy M.E. Neurological dysfunction and axonal degeneration in Charcot-Marie-Tooth disease type 1A. Brain 2000, 123:1516-1527.
88. Kuhlbrodt K., Herbarth B., Sock E., Hermans-Borgmeyer I., Wegner M. Sox10, a novel transcriptional modulator in glial cells. J Neurosci 1998, 18:237-250.
89. Lambert S., Davis J.Q., Bennett V. Morphogenesis of the node of Ranvier: Co-clusters of ankyrin and ankyrin-binding integral proteins define early developmental intermediates. J Neurosci 1997, 17:7025-7036.
90. Lee M.K., Marszalek J.R., Cleveland D.W. A mutant neurofilament subunit causes massive, selective motor neuron death: Implications for the pathogenesis of human motor neuron disease. Neuron 1994, 13:975-988.
91. Lemke G., Axel R. Isolation and sequence of a cDNA encoding the major structural protein of peripheral nerve myelin. Cell 1985, 40:501-508.
92. Low P.A. Hereditary hypertrophic neuropathy in the trembler mouse: Part 1: Histopathological studies: Light microscopy. J Neurol Sci 1976, 30:327-341.
93. Low P.A. Hereditary hypertrophic neuropathy in the trembler mouse: Part 2: Histopathological studies: Electron microscopy. J Neurol Sci 1976, 30:343-368.
94. Low P.A. The evolution of 'onion bulbs' in the hereditary hypertrophic neuropathy of the Trembler mouse. Neuropath Appl Neurobiol 1977, 3:81-92.
95. Low P.A., McLeod J.G. Hereditary demyelinating neuropathy in the trembler mouse. J Neurol Sci 1975, 26:565-575.
96. Lupski J., Garcia C. Charcot-Marie-Tooth peripheral neuropathies and related disorders. The Metabolic & Molecular Bases of Inherited Disease 2001, Vol. 3:5759-5788. McGraw-Hill, Amsterdam. C.R. Scriver, A.L. Beaudet, W.S. Sly, D. Valle, B. Childs, K.W. Kinzler, B. Vogelstein (Eds.).
97. Magyar J.P., Martini R., Ruelicke T., Aguzzi A., Adlkofer K., Dembic Z., Zielasek J., Toyka K.V., Suter U. Impaired differentiation of Schwann cells in transgenic mice with increased PMP22 gene dosage. J Neurosci 1996, 16:5351-5360.
98. Maier M., Berger P., Nave K.A., Suter U. Identification of the regulatory region of the peripheral myelin protein 22 (PMP22). gene that directs temporal and spatial expression in development and regeneration of peripheral nerves. Mol Cell Neurosci 2002, 20:93-109.
99. Maier M., Berger P., Suter U. Understanding Schwann cell-neurone interactions: The key to Charcot-Marie-Tooth disease?. J Anat 2002, 200:357-366.
100. Marrosu M.G., Vaccargiu S., Marrosu G., Vannelli A., Cianchetti C., Muntoni F. Charcot-Marie-Tooth disease type 2 associated with mutation of the myelin protein zero gene. Neurology 1998, 50:1397-1401.
101. Martini R. Animal models for inherited peripheral neuropathies. J Anat 1997, 191:321-336.
102. Martini R. Animal models for inherited peripheral neuropathies: Chances to find treatment strategies?. J Neurosci Res 2000, 61:244-250.
103. Martini R. The effect of myelinating Schwann cells on axons. Muscle Nerve 2001, 24:456-466.
104. Martini R., Zielasek J., Toyka K.V., Giese K.P., Schachner M. Protein zero (P0)-deficient mice show myelin degeneration in peripheral nerves characteristic of inherited human neuropathies. Nat. Genet. 1995, 11:281-286.
105. Maurer M., Kobsar I., Berghoff M., Schmid C.D., Carenini S., Martini R. Role of immune cells in animal models for inherited neuropathies: Facts and visions. J Anat 2002, 200:405-414.
106. Maurer M., Schmid C.D., Bootz F., Zielasek J., Toyka K.V., Oehen S., Martini R. Bone marrow transfer from wild-type mice reverts the beneficial effect of genetically mediated immune deficiency in myelin mutants. Mol Cell Neurosci 2001, 17:1094-1101.
107. Maycox P.R., Ortuno D., Burrola P., Kuhn R., Bieri P.L., Arrezo J.C., Lemke G. A transgenic mouse model for human hereditary neuropathy with liability to pressure palsies. Mol Cell Neurosci 1997, 8:405-416.
108. Mersiyanova I.V., Perepelov A.V., Polyakov A.V., Sitnikov V.F., Dadali E.L., Oparin R.B., Petrin A.N., Evgrafov O.V. A new variant of Charcot-Marie-Tooth disease type 2 is probably the result of a mutation in the neurofilament-light gene. Am J Hum Genet 2000, 67:37-46.
109. Moir R.D., Spann T.P. The structure and function of nuclear lamins: Implications for disease. Cell Mol Life Sci 2001, 58:1748-1757.
110. Mok H., Shin H., Kim S., Lee J.R., Yoon J., Kim E. Association of the kinesin superfamily motor protein KIF1Balpha with postsynaptic density-95 (PSD-95), synapse-associated protein-97, and synaptic scaffolding molecule PSD-95/discs large/zona occludens-1 proteins. J Neurosci 2002, 22:5253-5258.
111. Murphy P., Topilko P., Schneider-Maunoury S., Seitanidou T., Baron-Van Evercooren A., Charnay P. The regulation of Krox-20 expression reveals important steps in the control of peripheral glial cell development. Development 1996, 122:2847-2857.
112. Naef R., Adlkofer K., Lescher B., Suter U. Aberrant protein trafficking in Trembler suggests a disease mechanism for hereditary human peripheral neuropathies. Mol Cell Neurosci 1997, 9:13-25.
113. Nagarajan R., Le N., Mahoney H., Araki T., Milbrandt J. Deciphering peripheral nerve myelination by using Schwann cell expression profiling. Proc Natl Acad Sci U S A 2002, 99:8998-9003.
114. Nagarajan R., Svaren J., Le N., Araki T., Watson M., Milbrandt J. EGR2 mutations in inherited neuropathies dominant-negatively inhibit myelin gene expression. Neuron 2001, 30:355-368.
115. Nelis E., Haites N., Van Broeckhoven C. Mutations in the peripheral myelin genes and associated genes in inherited peripheral neuropathies. Hum Mutat 1999, 13:11-28.
116. Nelis E., Van Broeckhoven C., De Jonghe P., Lofgren A., Vandenberghe A., Latour P., Le Guern E., Brice A., Mostacciuolo M.L., Schiavon F., Palau F., Bort S., Upadhyaya M., Rocchi M., Archidiacono N., Mandich P., Bellone E., Silander K., Savontaus M.L., Navon R., Goldberg-Stern H., Estivill X., Volpini V., Friedl W., Gal A., et al. Estimation of the mutation frequencies in Charcot-Marie-Tooth disease type 1 and hereditary neuropathy with liability to pressure palsies: A European collaborative study. Eur J Hum Genet 1996, 4:25-33.
117. Nelles E., Butzler C., Jung D., Temme A., Gabriel H.D., Dahl U., Traub O., Stumpel F., Jungermann K., Zielasek J., Toyka K.V., Dermietzel R., Willecke K. Defective propagation of signals generated by sympathetic nerve stimulation in the liver of connexin32-deficient mice. Proc Natl Acad Sci U S A 1996, 93:9565-9570.
118. Neuberg D.H., Sancho S., Suter U. Altered molecular architecture of peripheral nerves in mice lacking the peripheral myelin protein 22 or connexin32. J Neurosci Res 1999, 58:612-623.
119. Nicholson S.M., Gomes D., de Nechaud B., Bruzzone R. Altered gene expression in Schwann cells of connexin32 knockout animals. J Neurosci Res 2001, 66:23-36.
120. Niemann S., Sereda M.W., Suter U., Griffiths I.R., Nave K.A. Uncoupling of myelin assembly and schwann cell differentiation by transgenic overexpression of peripheral myelin protein 22. J Neurosci 2000, 20:4120-4128.
121. Norreel J.C., Jamon M., Riviere G., Passage E., Fontes M., Clarac F. Behavioural profiling of a murine Charcot-Marie-Tooth disease type 1A model. Eur J Neurosci 2001, 13:1625-1634.
122. Notterpek L., Roux K.J., Amici S.A., Yazdanpour A., Rahner C., Fletcher B.S. Peripheral myelin protein 22 is a constituent of intercellular junctions in epithelia. Proc Natl Acad Sci U S A 2001, 98:14404-14409.
123. Notterpek L., Shooter E.M., Snipes G.J. Upregulation of the endosomal-lysosomal pathway in the trembler-J neuropathy. J Neurosci 1997, 17:4190-4200.
124. Paratore P., Hagedorn L., Floris J., Hari L., Kleber M., Suter U., Sommer L. Cell-intrinsic and cell-extrinsic cues regulating lineage decisions in multipotent neural crest-derived progenitor cells. Int J Dev Biol 46: 193-200 (2002) 2002, 46:193-200.
125. Pareyson D., Menichella D., Botti S., Sghirlanzoni A., Fallica E., Mora M., Ciano C., Shy M.E., Taroni F. Heterozygous null mutation in the P0 gene associated with mild Charcot-Marie-Tooth disease. Ann N Y Acad Sci 1999, 883:477-480.
126. Paramantier E., Braun C., Thomas J.L., Peyron F., Martinez S., Zalc B. PMP-22 expression in the central nervous system of the embryonic mouse defines potential transverse segments and longitudinal columns. J Comp Neurol 1997, 378:159-172.
127. Parmantier E., Lynn B., Lawson D., Turmaine M., Namini S.S., Chakrabarti L., McMahon A.P., Jessen K.R., Mirsky R. Schwann cell-derived Desert hedgehog controls the development of peripheral nerve sheaths. Neuron 1999, 23:713-724.
128. Paulson H.L., Garbern J.Y., Hoban T.F., Krajewski K.M., Lewis R.A., Fischbeck K.H., Grossman R.I., Lenkinski R., Kamholz J.A., Shy M.E. Transient central nervous system white matter abnormality in X-linked Charcot-Marie-Tooth disease. Ann Neurol 2002, 52:429-434.
129. Peirano R.I., Goerich D.E., Riethmacher D., Wegner M. Protein zero gene expression is regulated by the glial transcription factor Sox10. Mol Cell Biol 2000, 20:3198-3209.
130. Perea J., Robertson A., Tolmachova T., Muddle J., King R.H., Ponsford S., Thomas P.K., Huxley C. Induced myelination and demyelination in a conditional mouse model of Charcot-Marie-Tooth disease type 1A. Hum Mol Genet 2001, 10:1007-1018.
131. Perez-Olle R., Leung C.L., Liem R.K. Effects of Charcot-Marie-Tooth-linked mutations of the neurofilament light subunit on intermediate filament formation. J Cell Sci 2002, 115:4937-4946.
132. Perkins C.S., Aguayo A.J., Bray G.M. Schwann cell multiplication in Trembler mice. Neuropathol Appl Neurobiol 1981, 7:115-126.
133. Phillips J.P., Warner L.E., Lupski J.R., Garg B.P. Congenital hypomyelinating neuropathy: Two patients with long-term follow-up. Pediatr. Neurol. 1999, 20:226-232.
134. Pingault V., Bondurand N., Kuhlbrodt K., Goerich D.E., Prehu M.O., Puliti A., Herbarth B., Hermans-Borgmeyer I., Legius E., Matthijs G., Amiel J., Lyonnet S., Ceccherini I., Romeo G., Smith J.C., Read A.P., Wegner M., Goossens M. SOX10 mutations in patients with Waardenburg-Hirschsprung disease. Nat Genet 1998, 18:171-173.
135. Pingault V., Bondurand N., Le Caignec C., Tardieu S., Lemort N., Dubourg O., Le Guern E., Goossens M., Boespflug-Tanguy O. The SOX10 transcription factor: Evaluation as a candidate gene for central and peripheral hereditary myelin disorders. J Neurol 2001, 248:496-499.
136. Previtali S.C., Quattrini A., Fasolini M., Panzeri M.C., Villa A., Filbin M.T., Li W., Chiu S.Y., Messing A., Wrabetz L., Feltri M.L. Epitope-tagged P(0). glycoprotein causes charcot-marie-tooth-like neuropathy in transgenic mice. J. Cell Biol. 2000, 151:1035-1046.
137. Robertson A., Perea J., Tolmachova T., Thomas P.K., Huxley C. Effects of mouse strain, position of integration and tetracycline analogue on the tetracycline conditional system in transgenic mice. Gene 2002, 282:65-74.
138. Robertson A.M., Huxley C., King R.H., Thomas P.K. Development of early postnatal peripheral nerve abnormalities in Trembler-J and PMP22 transgenic mice. J Anat 1999, 195:331-339.
139. Robertson A.M., King R.H., Muddle J.R., Thomas P.K. Abnormal Schwann cell/axon interactions in the Trembler-J mouse. J Anat 1997, 190:423-432.
140. Robertson A.M., Perea J., McGuigan A., King R.H., Muddle J.R., Gabreels-Festen A.A., Thomas P.K., Huxley C. Comparison of a new pmp22 transgenic mouse line with other mouse models and human patients with CMT1A. J Anat 2002, 200:377-390.
141. Ryan M.C., Shooter E.M., Notterpek L. Aggresome formation in neuropathy models based on peripheral myelin protein 22 mutations. Neurobiol Dis 2002, 10:109-118.
142. Sahenk Z. Abnormal Schwann cell-axon interactions in CMT neuropathies. The effects of mutant Schwann cells on the axonal cytoskeleton and regenration-associated myelination. Ann N Y Acad Sci 1999, 883:415-426.
143. Sahenk Z., Chen L., Freimer M. A novel PMP22 point mutation causing HNPP phenotype: Studies on nerve xenografts. Neurology 1998, 51:702-707.
144. Sahenk Z., Chen L., Mendell J.R. Effects of PMP22 duplication and deletions on the axonal cytoskeleton. Ann Neurol 1999, 45:16-24.
145. Sakai Y., Nakabayashi O., Kikuchi T., Wada K. Identification of break points in mutated PMP22 gene in a new Trembler (Tr-Ncnp). mouse. Neuroscience 1999, 88:989-991.
146. Salles J., Sargueil F., Knoll-Gellida A., Witters L.A., Shy M., Jiang H., Cassagne C., Garbay B. Fatty acid synthase expression during peripheral nervous system myelination. Brain Res Mol Brain Res 2002, 101:52-58.
147. Sancho S., Magyar J.P., Aguzzi A., Suter U. Distal axonopathy in peripheral nerves of PMP22-mutant mice. Brain 1999, 122:1563-1577.
148. Sancho S., Young P., Suter U. Regulation of Schwann cell proliferation and apoptosis in PMP22-deficient mice and mouse models of Charcot-Marie-Tooth disease type 1A. Brain 2001, 124:2177-2187.
149. Sargueil F., Knoll A., Salles J., Garbay B., Cassagne C. High metabolism and subsequent elongation of 3-hydroxyeicosanoyl-CoA in very-long-chain fatty acid deficient PNS of Trembler mice. Neurosci Lett 1999, 273:29-32.
150. Scherer S.S., Bone L.J., Deschenes S.M., Abel A., Balice-Gordon R.J., Fischbeck K.H. The role of the gap junction protein connexin32 in the pathogenesis of X-linked Charcot-Marie-Tooth disease. Novartis Found Symp 1999, 219:175-185.
151. Scherer S.S., Deschenes S.M., Xu Y.T., Grinspan J.B., Fischbeck K.H., Paul D.L. Connexin32 is a myelin-related protein in the PNS and CNS. J Neurosci 1995, 15:8281-8294.
152. Scherer S.S., Fischbeck K.H. Is CMTX an axonopathy?. Neurology 1999, 52:432-433.
153. Scherer S.S., Xu Y.T., Bannerman P.G., Sherman D.L., Brophy P.J. Periaxin expression in myelinating Schwann cells: Modulation by axon-glial interactions and polarized localization during development. Development 1995, 121:4265-4273.
154. Scherer S.S., Xu Y.T., Nelles E., Fischbeck K., Willecke K., Bone L.J. Connexin32-null mice develop demyelinating peripheral neuropathy. Glia 1998, 24:8-20.
155. Schmid C.D., Stienekemeier M., Oehen S., Bootz F., Zielasek J., Gold R., Toyka K.V., Schachner M., Martini R. Immune deficiency in mouse models for inherited peripheral neuropathies leads to improved myelin maintenance. J Neurosci 2000, 20:729-735.
156. Schneider-Maunoury S., Topilko P., Seitandou T., Levi G., Cohen-Tannoudji M., Pournin S., Babinet C., Charnay P. Disruption of Krox-20 results in alteration of rhombomeres 3 and 5 in the developing hindbrain. Cell 1993, 75:1199-1214.
157. Schneider-Schaulies J., Brunn A.V., Schachner M. Recombinant peripheral myelin protein Po confers both adhesion and neurite outgrowth-promoting properties. J. Neuroscience Research 1990, 27:286-297.
158. Senderek J., Hermanns B., Lehmann U., Bergmann C., Marx G., Kabus C., Timmerman V., Stoltenburg-Didinger G., Schroder J.M. Charcot-Marie-Tooth neuropathy type 2 and P0 point mutations: Two novel amino acid substitutions (Asp61Gly; Tyr119Cys)., and a possible "hotspot" on Thr124Met. Brain Pathol 2000, 10:235-248.
159. Sereda M., Griffiths I., Puhlhofer A., Stewart H., Rossner M.J., Zimmerman F., Magyar J.P., Schneider A., Hund E., Meinck H.M., Suter U., Nave K.A. A transgenic rat model of Charcot-Marie-Tooth disease. Neuron 1996, 16:1049-1060.
160. Sghirlanzoni A., Pareyson D., Balestrini M.R., Bellone E., Berta E., Ciano C., Mandich P., Marazzi R. HMSN III phenotype due to homozygous expression of a dominant HMSN II gene. Neurology 1992, 42:2201-2204.
161. Shapiro L., Doyle J.P., Hensley P., Colman D.R., Hendrickson W.A. Crystal structure of the extracellular domain from P0, the major structural protein of peripheral nerve myelin. Neuron 1996, 17:435-449.
162. Sherman D.L., Fabrizi C., Gillespie C.S., Brophy P.J. Specific disruption of a schwann cell dystrophin-related protein complex in a demyelinating neuropathy. Neuron 2001, 30:677-687.
163. Shy M.E., Arroyo E., Sladky J., Menichella D., Jiang H., Xu W., Kamholz J., Scherer S.S. Heterozygous P0 knockout mice develop a peripheral neuropathy that resembles chronic inflammatory demyelinating polyneuropathy (CIDP). J Neuropathol Exp Neurol 1997, 56:811-821.
164. Shy M.E., Hobson G., Jain M., Boespflug-Tanguy O., Garbern J., Sperle K., Li W., Gow A., Rodriguez D., Bertini E., Mancias P., Krajewski K., Lewis R., Kamholz J. Schwann cell expression of PLP1 but not DM20 is necessary to prevent neuropathy. Ann Neurol 2003, 53:354-365.
165. Southwood C.M., Garbern J., Jiang W., Gow A. The unfolded protein response modulates disease severity in Pelizaeus-Merzbacher disease. Neuron 2002, 36:585-596.
166. Stolt C.C., Rehberg S., Ader M., Lommes P., Riethmacher D., Schachner M., Bartsch U., Wegner M. Terminal differentiation of myelin-forming oligodendrocytes depends on the transcription factor Sox10. Genes Dev 2002, 16:165-170.
167. Suh J.G., Ichihara N., Saigoh K., Nakabayashi O., Yamanishi T., Tanaka K., Wada K., Kikuchi T. An in-frame deletion in peripheral myelin protein-22 gene causes hypomyelination and cell death of the Schwann cells in the new Trembler mutant mice. Neuroscience 1997, 79:735-744.
168. Sullivan T., Escalante-Alcalde D., Bhatt H., Anver M., Bhat N., Nagashima K., Stewart C.L., Burke B. Loss of A-type lamin expression compromises nuclear envelope integrity leading to muscular dystrophy. J Cell Biol 1999, 147:913-920.
169. Suter U., Moskow J.J., Welcher A.A., Snipes G.J., Kosaras B., Sidman R.L., Buchberg A.M., Shooter E.M. A leucine-to-proline mutation in the putative first transmembrane domain of the 22-kDa peripheral myelin protein in the trembler-J mouse. Proc Natl Acad Sci U S A 1992, 89:4382-4386.
170. Suter U., Nave K.A. Transgenic mouse models of CMT1A and HNPP. Ann N Y Acad Sci 1999, 883:247-253.
171. Suter U., Snipes G.J., Schoener-Scott R., Welcher A.A., Pareek S., Lupski J.R., Murphy R.A., Shooter E.M., Patel P.I. Regulation of tissue-specific expression of alternative peripheral myelin protein-22 (PMP22). gene transcripts by two promoters. J Biol Chem 1994, 269:25795-25808.
172. Suter U., Welcher A.A., Ozcelik T., Snipes G.J., Kosaras B., Francke U., Billings-Gagliardi S., Sidman R.L., Shooter E.M. Trembler mouse carries a point mutation in a myelin gene. Nature 1992, 356:241-244.
173. Suter U., Welcher A.A., Snipes G.J. Progress in the molecular understanding of hereditary peripheral neuropathies reveals new insights into the biology of the peripheral nervous system. Trends Neurosci 1993, 16:50-56.
174. Svaren J., Sevetson B.R., Golda T., Stanton J.J., Swirnoff A.H., Milbrandt J. Novel mutants of NAB corepressors enhance activation by Egr transactivators. Embo J 1998, 17:6010-6019.
175. Swiatek P.J., Gridley T. Perinatal lethality and defects in hindbrain development in mice homozygous for a targeted mutation of the zinc finger gene Krox20. Genes Dev 1993, 7:2071-2084.
176. Taillebourg E., Buart S., Charnay P. Conditional, floxed allele of the Krox20 gene. Genesis 2002, 32:112-113.
177. Takashima H., Boerkoel C.F., De Jonghe P., Ceuterick C., Martin J.J., Voit T., Schroder J.M., Williams A., Brophy P.J., Timmerman V., Lupski J.R. Periaxin mutations cause a broad spectrum of demyelinating neuropathies. Ann Neurol 2002, 51:709-715.
178. Taylor V., Zgraggen C., Naef R., Suter U. Membrane topology of peripheral myelin protein 22. J Neurosci Res 2000, 62:15-27.
179. Temme A., Buchmann A., Gabriel H.D., Nelles E., Schwarz M., Willecke K. High incidence of spontaneous and chemically induced liver tumors in mice deficient for connexin32. Curr Biol 1997, 7:713-716.
180. Tobler A.R., Liu N., Mueller L., Shooter E.M. Differential aggregation of the Trembler and Trembler J mutants of peripheral myelin protein 22. Proc Natl Acad Sci U S A 2002, 99:483-488.
181. Tobler A.R., Notterpek L., Naef R., Taylor V., Suter U., Shooter E.M. Transport of Trembler-J mutant peripheral myelin protein 22 is blocked in the intermediate compartment and affects the transport of the wild-type protein by direct interaction. J Neurosci 1999, 19:2027-2036.
182. Topilko P., Schneider-Maunoury S., Levi G., Baron-Van Evercooren A., Chennoufi A.B., Seitanidou T., Babinet C., Charnay P. Krox-20 controls myelination in the peripheral nervous system. Nature 1994, 371:796-799.
183. Toyka K.V., Zielasek J., Ricker K., Adlkofer K., Suter U. Hereditary neuromyotonia: A mouse model associated with deficiency or increased gene dosage of the PMP22 gene. J Neurol Neurosurg Psychiatry 1997, 63:812-813.
184. Umehara F., Tate G., Itoh K., Yamaguchi N., Douchi T., Mitsuya T., Osame M. A novel mutation of desert hedgehog in a patient with 46,XY partial gonadal dysgenesis accompanied by minifascicular neuropathy. Am J Hum Genet 2000, 67:1302-1305.
185. Valentijn L.J., Baas F., Wolterman R.A., Hoogendijk J.E., van Den Bosch N.H., Zorn I., Gabreels-Festen A.W., de Visser M., Bolhuis P.A. Identical point mutations of PMP-22 in Trembler-J mouse and Charcot-Marie-Tooth disease type 1A. Nat Genet 1992, 2:288-291.
186. Valentijn L.J., Ouvrier R.A., van den Bosch N.H., Bolhuis P.A., Baas F., Nicholson G.A. Dejerine-Sottas neuropathy is associated with a de novo PMP22 mutation. Hum Mutat 1995, 5:76-80.
187. Vallat J.M., Sindou P., Garbay B., Preux P.M., Anani T., Richard L., Diot M. Expression of myelin proteins in the adult heterozygous Trembler mouse. Acta Neuropathol (Berl) 1999, 98:281-287.
188. Voiculescu O., Charnay P., Schneider-Maunoury S. Expression pattern of a Krox-20/Cre knock-in allele in the developing hindbrain, bones, and peripheral nervous system. Genesis 2000, 26:123-126.
189. Wang H., Allen M.L., Grigg J.J., Noebels J.L., Tempel B.L. Hypomyelination alters K+ channel expression in mouse mutants shiverer and Trembler. Neuron 1995, 15:1337-1347.
190. Warner L.E., Hilz M.J., Appel S.T., Killian J.M., Kolodny E.H., Karpati G., Carpenter S., Watters G.V., Wheeler C., Witt D., Bodell A., Nelis E., Broeckhoven C.V., Lupski J.R. Clinical phenotypes of different MPZ (Po) mutations may include Charcot-Marie-Tooth type 1b, Dejerine-Sottas, and Congenital Hypomyelination. Neuron 1996, 17:451-460.
191. Warner L.E., Mancias P., Butler I.J., McDonald C.M., Keppen L., Koob K.G., Lupski J.R. Mutations in the early growth response 2 (EGR2) gene are associated with hereditary myelinopathies. Nat Genet 1998, 18:382-384.
192. Warner L.E., Svaren J., Milbrandt J., Lupski J.R. Functional consequences of mutations in the early growth response 2 gene (EGR2). correlate with severity of human myelinopathies. Hum Mol Genet 1999, 8:1245-1251.
193. Werner H., Dimou L., Klugmann M., Pfeiffer S., Nave K.A. Multiple splice isoforms of proteolipid M6B in neurons and oligodendrocytes. Mol Cell Neurosci 2001, 18:593-605.
194. Willecke K., Temme A., Teubner B., Ott T. Characterization of targeted connexin32-deficient mice: A model for the human Charcot-Marie-Tooth (X-type). inherited disease. Ann N Y Acad Sci 1999, 883:302-309.
195. Wilson H.L., Wilson S.A., Surprenant A., North R.A. Epithelial membrane proteins induce membrane blebbing and interact with the P2X7 receptor C-terminus. J Biol Chem 2002, in press.
196. Windebank A.J. Inherited recurrent neuropathy. Peripheral Neuropathy 1993, 1094-1136. WB Saunders, New York. P.J. Dyck, P.K. Thomas, J.W. Griffin, P.A. Low, J.F. Poduslo (Eds.).
197. Wong M.H., Filbin M.T. Dominant-negative effect on adhesion by myelin Po protein truncated in its cytoplasmic domain. J. Cell Biol. 1996, 134:1531-1541.
198. Wrabetz L., D'Antonio M., Dati G., Fratta P., Previtali S., Imperiale D., Zielasek J., Toyka K., Messing A., Feltri M.-L., Quattrini A. Transgenic mice expressing the CMT1B mutant Mpz(delser63). develop demyelinating neuropathy. 2002 Abstract Viewer/Itinerary Planner 2002, (Online), Program No. 523.527, Society for Neuroscience, Washington, DC.
199. Wrabetz L., Feltri M.L. Do Schwann cells stop, DR(o)P2, and roll?. Neuron 2001, 30:642-644.
200. Wrabetz L., Feltri M.L., Hanemann C.O., Müller H.W. The molecular genetics of hereditary demyelinating neuropathies. Glial Cell Development: Basic Principles and Clinical Relevance 2001, 327-351. Oxford University Press. K.R. Jessen, W.R. Richardson (Eds.).
201. Wrabetz L., Feltri M.L., Quattrini A., Imperiale D., Previtali S., D'Antonio M., Martini R., Yin X., Trapp B.D., Zhou L., Chiu S.Y., Messing A. P(0) glycoprotein overexpression causes congenital hypomyelination of peripheral nerves. J Cell Biol 2000, 148:1021-1034.
202. Yin X., Crawford T.O., Griffin J.W., Tu P., Lee V.M., Li C., Roder J., Trapp B.D. Myelin-associated glycoprotein is a myelin signal that modulates the caliber of myelinated axons. J Neurosci 1998, 18:1953-1962.
203. Yin X., Kidd G.J., Wrabetz L., Feltri M.L., Messing A., Trapp B.D. Schwann cell myelination requires timely and precise targeting of P(0). protein. J Cell Biol 2000, 148:1009-1020.
204. Yoshihara T., Yamamoto M., Hattori N., Misu K., Mori K., Koike H., Sobue G. Identification of novel sequence variants in the neurofilament-light gene in a Japanese population: Analysis of Charcot-Marie-Tooth disease patients and normal individuals. J Peripher Nerv Syst 2002, 7:221-224.
205. Zhang K., Filbin M.T. Myelin Po protein mutated at Cys21 has a dominant-negative effect on adhesion of wild type Po. J. Neurosci Res. 1998, 53:1-6.
206. Zhao C., Takita J., Tanaka Y., Setou M., Nakagawa T., Takeda S., Yang H.W., Terada S., Nakata T., Takei Y., Saito M., Tsuji S., Hayashi Y., Hirokawa N. Charcot-Marie-Tooth disease type 2A caused by mutation in a microtubule motor KIF1Bbeta. Cell 2001, 105:587-597.
207. Zhu Q., Couillard-Despres S., Julien J.P. Delayed maturation of regenerating myelinated axons in mice lacking neurofilaments. Exp Neurol 1997, 148:299-316.
208. Zielasek J., Martini R., Suter U., Toyka K.V. Neuromyotonia in mice with hereditary myelinopathies. Muscle Nerve 2000, 23:696-701.
209. Zielasek J., Martini R., Toyka K.V. Functional Abnormalities in P-0-Deficient Mice Resemble Human Hereditary Neuropathies Linked to P-0 Gene Mutations. Muscle & Nerve 1996, 19:946-952.